Will AbbVie’s $10.9 Billion Acquisition Shape Its Dividend?
AbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Learn about retirement plans that might be better than a 401k. Enhance your retirement strategy with informed choices.
27,827 articlesAbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
New York's transit agency filed a federal lawsuit against the federal government after nearly $60 million in subway f...
A sweeping regulatory bill could transform how Russians trade and use digital assets. As two votes stand between now ...
AI is changing every industry—and with the right approach, you can uncover millionaire-maker artificial intelligence ...
A federal probe into Tesla's FSD system raises questions for investors about safety, costs, and stock risk. This guid...
A $130,000 insider sale at CorVel raises questions for investors. This guide breaks down what the move could mean, ho...
When a growth stock slips, investors scramble to understand if the fall is temporary or the start of a bigger trend. ...
Lake Tahoe faces an abrupt energy reallocation as NV Energy shifts capacity toward data centers. The move could jeopa...
A large fund sold a sizable stake, and the stock still lagged the market. This look breaks down what happened, why it...
A clear, investor-focused guide to the IMSR 2025 Earnings Transcript. Learn what the numbers mean for the company’s p...
Avantis International Equity ETF AVDE posted a 23.6% trailing-12-month gain, signaling durable income from global div...
Meta Platforms signals a cloud compute push, aiming to sell AI capacity directly to enterprises amid a record capex c...